Alphamab Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 366
Employees
  • Stock Symbol
  • 09966
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $1.03
  • (As of Monday Closing)

Alphamab General Information

Description

Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in discovery, development manufacturing and commercialization of innovative therapeutics for cancer treatment.

Contact Information

Website
www.alphamab.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Stock Exchange
HKG
Primary Office
  • 218 XingHu Street
  • Suzhou Industrial Park, Bldg. C23
  • Suzhou, Jiangsu 215125
  • China
+86 0512 0000 0000

Alphamab Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alphamab Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.03 $1.05 $0.98 - $3.70 $964M 938M 3.04M -$0.10

Alphamab Financials Summary

In Thousands,
USD 		TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 2,713,526 1,668,475 1,693,103
Revenue 0 0 0 0
EBITDA (89,544) (65,205) (122,475) (28,984)
Net Income (89,294) (61,918) (120,519) (22,651)
Total Assets 386,716 404,011 407,984 120,205
Total Debt 48,443 34,103 36,185 16,139
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Alphamab Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alphamab‘s full profile, request access.

Request a free trial

Alphamab Executive Team (4)

Name Title Board Seat Contact Info
Ting Xu Ph.D Chief Executive Officer & Chairman
XU Weihao Chief Financial Officer
Johannes Nippgen Chief Medical Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Alphamab Board Members (1)

Name Representing Role Since
Ting Xu Ph.D Alphamab Chief Executive Officer & Chairman 000 0000
To view Alphamab’s complete board members history, request access »

Alphamab Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alphamab Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alphamab‘s full profile, request access.

Request a free trial

Alphamab Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 19-Apr-2019 000000000 Laboratory Services (Healthcare)
00000000000 31-Dec-2016 00000 0000 Laboratory Services (Healthcare)
SmartNuclide 21-Mar-2016 Seed Round Drug Discovery
To view Alphamab’s complete investments history, request access »